These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26780721)

  • 1. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.
    Guan H; Singh UP; Rao R; Mrelashvili D; Sen S; Hao H; Zumbrun EE; Singh NP; Nagarkatti PS; Nagarkatti M
    Immunology; 2016 Apr; 147(4):488-98. PubMed ID: 26780721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
    Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH
    PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
    J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
    Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
    J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients.
    Lindberg RL; Hoffmann F; Mehling M; Kuhle J; Kappos L
    Eur J Immunol; 2010 Mar; 40(3):888-98. PubMed ID: 20148420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
    Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
    Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta.
    Karimi L; Eskandari N; Shaygannejad V; Zare N; Andalib A; Khanahmad H; Mirmosayyeb O
    Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):416-425. PubMed ID: 33463108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-140-5p regulates T cell differentiation and attenuates experimental autoimmune encephalomyelitis by affecting CD4
    Zhu S; Zhang X; Guan H; Huang F; Wu L; Hou D; Zheng Z; Yu M; Huang L; Ge L
    Int Immunopharmacol; 2019 Oct; 75():105778. PubMed ID: 31494340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA Expression Profiling Identifies miR-125a-5p Promoting T Helper 1 Cells Response in the Pathogenesis of Hashimoto's Thyroiditis.
    Liu Y; Ding X; Xiong S; Wang X; Tang X; Wang L; Wang S; Peng H
    Front Immunol; 2020; 11():1195. PubMed ID: 32595646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-155 in CD4(+) T Cells Promoted Th1 Bias in Patients With Unstable Angina.
    Chen Y; Li L; Lu Y; Su Q; Sun Y; Liu Y; Yang D
    J Cell Physiol; 2015 Oct; 230(10):2498-509. PubMed ID: 25760478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranscriptional Interaction Between miR-450a-5p and miR-28-5p and STAT1 mRNA Triggers Osteoblastic Differentiation of Human Mesenchymal Stem Cells.
    Dernowsek JA; Pereira MC; Fornari TA; Macedo C; Assis AF; Donate PB; Bombonato-Prado KF; Passos-Bueno MR; Passos GA
    J Cell Biochem; 2017 Nov; 118(11):4045-4062. PubMed ID: 28407302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.
    Zhang F; Liu G; Wei C; Gao C; Hao J
    FASEB J; 2017 Feb; 31(2):519-525. PubMed ID: 27756768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis.
    Li ZH; Wang YF; He DD; Zhang XM; Zhou YL; Yue H; Huang S; Fu Z; Zhang LY; Mao ZQ; Li S; Zhang CY; Chen X; Fu J
    Aging (Albany NY); 2019 Jul; 11(13):4463-4477. PubMed ID: 31326963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease.
    Torabi S; Tamaddon M; Asadolahi M; Shokri G; Tavakoli R; Tasharrofi N; Rezaei R; Tavakolpour V; Sazegar H; Kouhkan F
    Immunogenetics; 2019 Feb; 71(2):87-95. PubMed ID: 30310937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
    Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
    Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.